Watchlist Price Alert

Oyster Point Pharma Inc. (OYST)

NASDAQ: OYST · Real-Time Price · USD

11.17

0.00 (0.00%)

At close: Dec 30, 2022, 9:00 PM

Oyster Point Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q4 2018
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Dec 31, 2018
Cash & Equivalents	68.8M	104.88M	143.36M	193.37M	184.17M	154.81M	175.91M	192.59M	214.33M	226.75M	128.63M	139.15M	72.28M	83.36M	5.23M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	886K	886K	886K	886K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	5.69M	5.13M	3.22M	1.08M	2.7M	91K	91K	61K	61K	61K	61K	51K	2.3M	437K	20K
Receivables	13.18M	10.92M	5.74M	6.66M	2.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	6.96M	6.64M	4.09M	6.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.76M	10.28M	14.16M	9.14M	3.02M	4.08M	6.74M	3.78M	861K	1.82M	2.39M	3.03M	4.62M	4.05M	390K
Total Current Assets	97.71M	132.72M	167.35M	215.25M	189.69M	158.89M	182.65M	196.37M	215.19M	228.56M	131.02M	142.18M	76.89M	87.41M	5.62M
Property-Plant & Equipment	4.92M	5.2M	5.26M	5.4M	2.63M	2.53M	2.03M	1.48M	1.24M	1.36M	1.23M	978K	879K	40K	66K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	11.49M	11.22M	9.37M	7.37M	5.32M	2.62M	2.12M	1.54M	1.3M	1.42M	1.29M	1.03M	3.18M	477K	86K
Total Assets	109.2M	143.94M	176.72M	222.62M	195.01M	161.5M	184.77M	197.91M	216.5M	229.98M	132.31M	143.21M	80.08M	87.89M	5.7M
Account Payables	4.14M	4.72M	2.6M	6.5M	3.51M	2.33M	7.09M	2.28M	2.29M	3.76M	6.89M	500K	1.83M	2.09M	462K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-533K	-418K	-409K	-400K	-391K	-296K	-288K	n/a	n/a
Short-Term Debt	692K	718K	715K	795K	481K	545K	533K	418K	409K	400K	391K	296K	288K	n/a	n/a
Other Current Liabilities	24.36M	25.7M	19.71M	21.51M	11.17M	6.59M	6.64M	8.7M	7.16M	4.93M	2.87M	4.9M	3.75M	1.46M	478K
Total Current Liabilities	29.2M	31.13M	23.03M	28.8M	15.16M	9.47M	13.74M	10.98M	9.45M	8.69M	9.77M	5.4M	5.58M	3.54M	940K
Long-Term Debt	94.03M	93.42M	92.64M	91.93M	42.1M	248K	388K	269K	376K	482K	584K	512K	594K	n/a	n/a
Other Long-Term Liabilities	8.18M	8.6M	5.06M	2.35M	238K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	135.85M	n/a	43.01M
Total Long-Term Liabilities	102.21M	102.03M	97.7M	94.28M	42.34M	248K	388K	269K	376K	482K	584K	512K	136.45M	n/a	43.01M
Total Liabilities	131.4M	133.16M	120.73M	123.08M	57.5M	9.72M	14.12M	11.25M	9.82M	9.17M	10.35M	5.91M	142.03M	3.54M	43.95M
Total Debt	94.72M	94.14M	93.36M	92.73M	42.58M	793K	921K	687K	752K	882K	975K	808K	882K	36K	62K
Common Stock	27K	27K	27K	27K	26K	26K	26K	26K	26K	26K	21K	21K	1K	16K	1K
Retained Earnings	-389.99M	-353.24M	-303.3M	-255.41M	-213.35M	-195.68M	-173.66M	-154.75M	-132.52M	-116.21M	-100.75M	-84.23M	-64.51M	-53.01M	-38.52M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-19K	-43M	n/a	n/a
Shareholders Equity	-22.2M	10.78M	55.99M	99.54M	137.51M	151.78M	170.65M	186.66M	206.67M	220.81M	121.96M	137.3M	-61.95M	84.34M	-38.24M
Total Investments	886K	886K	886K	886K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a